Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Four)
Mad in America
OCTOBER 30, 2023
It was an NIMH-financed trial, which randomised 1,493 “real-world” patients with schizophrenia to olanzapine, quetiapine, risperidone or ziprasidone, or to a very old drug, perphenazine, marketed in 1957. STAR*D was also financed by the NIMH. 17:58 For CATIE, there were 191 records on PubMed. It is a remarkable story of fraud.
Let's personalize your content